Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma With Solitary Huge Tumor
Not Applicable
- Conditions
- Survival RateCarcinoma, Hepatocellular
- Interventions
- Procedure: hepatic resectionProcedure: TACE
- First Posted Date
- 2017-06-19
- Last Posted Date
- 2018-04-13
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 100
- Registration Number
- NCT03191123
- Locations
- 🇨🇳
Hepatic surgery center, Tong ji Hospital, Wuhan, Hubei, China
A Trial to Compare Surgery With Sorafenib for Hepatic Celluler Cancer With Portal Vein Tumor Thrombosis
- First Posted Date
- 2017-06-07
- Last Posted Date
- 2017-12-21
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 54
- Registration Number
- NCT03178656
- Locations
- 🇨🇳
Hepatic surgery center, Tong ji Hospital, Wuhan, Hubei, China
Blood Flow Index as an Indicator of Successful Peripheral Nerve Block
Completed
- Conditions
- Laser
- First Posted Date
- 2017-05-30
- Last Posted Date
- 2017-09-06
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 110
- Registration Number
- NCT03169517
- Locations
- 🇨🇳
Tongji Hospital, Wuhan, Hubei, China
A Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic Neuropathy
Phase 2
Active, not recruiting
- Conditions
- Leber Hereditary Optic Neuropathy
- Interventions
- First Posted Date
- 2017-05-15
- Last Posted Date
- 2020-09-17
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 159
- Registration Number
- NCT03153293
- Locations
- 🇨🇳
Department of Ophthalmology，Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
The Epigenetic Modification in OPRM1 on Postoperative Analgesia and Side Effect Induced by Sufentanil
Phase 4
- Conditions
- Epigenetics
- Interventions
- First Posted Date
- 2017-05-01
- Last Posted Date
- 2017-05-01
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 100
- Registration Number
- NCT03135795
- Locations
- 🇨🇳
Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Brain Protection Effect of Selective Head Cooling and Dexmedetomidine in Patients Undergoing Liver Transplantation
Phase 2
- Conditions
- Liver Transplant; Complications
- Interventions
- Device: Cooling Helmet
- First Posted Date
- 2017-04-05
- Last Posted Date
- 2019-05-29
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 100
- Registration Number
- NCT03102359
- Locations
- 🇨🇳
Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology, Wuhan, Hubei, China
Tongji Maternal and Child Health Cohort
- Conditions
- Weight GainDiet HabitGrowth and DevelopmentBirth OutcomesBreast FeedingMaternal; Diabetes Mellitus, Affecting FetusPregnancy Complications
- First Posted Date
- 2017-04-04
- Last Posted Date
- 2020-08-04
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 8649
- Registration Number
- NCT03099837
Paravertebral Block Versus Epidural Anesthesia for Percutaneous Nephrolithotomy
Not Applicable
Completed
- Conditions
- Kidney Calculi
- Interventions
- Procedure: epidural anesthesiaProcedure: paravertebral block
- First Posted Date
- 2017-01-12
- Last Posted Date
- 2019-10-30
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 50
- Registration Number
- NCT03018899
- Locations
- 🇨🇳
Tongji Hospital, Wuhan, Hubei, China
Thromboprophylaxis After Surgery for Gynecologic Malignancy in China
Phase 3
Completed
- Conditions
- ArgatrobanGynecologic NeoplasmsLow Molecular Weight HeparinVenous Thromboembolism
- Interventions
- First Posted Date
- 2016-10-17
- Last Posted Date
- 2019-05-14
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 315
- Registration Number
- NCT02935530
- Locations
- 🇨🇳
Tongji Hospital, Wuhan, Hubei, China
Study of Molecular-targeted Therapy Using Zinc Finger Nuclease in Cervical Precancerous Lesions
Phase 1
- Conditions
- Human Papillomavirus-Related Malignant Neoplasm
- Interventions
- Biological: ZFN-603 and ZFN-758
- First Posted Date
- 2016-06-15
- Last Posted Date
- 2017-07-12
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 20
- Registration Number
- NCT02800369
- Locations
- 🇨🇳
Tongji Hospital, Wuhan, Hubei, China
© Copyright 2025. All Rights Reserved by MedPath